Our findings are supported by Saran et al.31 who showed that the pro-apoptotic antagonist of Wnt signalling, sFRP4, causes endothelial dysfunction by suppressing NO–cGMP signalling. The gene discussed is SFRP4; the disease is endothelial dysfunction.